Myofascial Trigger Point Pain, Neck Pain
Conditions
Keywords
Vibration, Pressure Pain Threshold, Trigger Points, Neck Pain
Brief summary
The aim of this study was to investigate the efficacy of a self-administered vibration therapy treatment on neck pain, disability and pressure pain thresholds in patients with non-specific neck pain and myofascial trigger points (MTrPs). The investigators hypothesized that patients receiving vibration therapy would report less perceived neck pain, disability and present higher PPTs after receiving vibration therapy when compared to a control no-treatment group.
Detailed description
Myofascial trigger points (MTrPs) are a common source of (regional) pain in patients presenting with musculoskeletal pain. Mechanical vibration has been suggested as a treatment for pain relief. In this study, the effects of vibration therapy on people with non-specific neck pain and MTrPs were investigated. Seventeen chronic non-specific neck pain patients were randomly assigned to a treatment (vibration group, n = 9) or control group (n = 8). Vibration group received 10 self-administered sessions of vibration therapy (45-50 Hz for 15 minutes with the subject laying in supine). Perceived neck pain and disability and pressure pain thresholds over MTrPs of the upper trapezius and levator scapulae bilateraly were measured at baseline and after the first, five and 10 treatment sessions.
Interventions
DEVICEShindo® vibration mattress
vibration therapy was self-administered while the subject was laying in supine in a polyurethane mattress
Sponsors
University of Valencia
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* a score of ≥ 5/50 in Neck Disability Index * active or latent myofascial trigger points in upper trapezius or levator scapulae muscles
Exclusion criteria
* previous cervical spine surgery * cervical radiculopathy * severe systemic disease * fibromyalgia * other widespread musculoskeletal pain syndromes * patients being treated with medication or physiotherapy within the last 4 weeks
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pressure Pain Threshold (PPT) | 10 days | Pain tolerance was measured at baseline (T0) and after the first (T1), five (T5) and 10 treatment sessions (T10). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Neck Disability Index (NDI) | 10 days | Perceived neck pain and disability were measured at baseline (T0) and after the first (T1), five (T5) and 10 treatment sessions (T10). |
Countries
Spain
Outcome results
None listed